Atea Pharmaceuticals Inc (AVIR)

Jan 06, 2026

Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Jan 06, 2026

Jan 05, 2026

Critical Survey: Atea Pharmaceuticals (NASDAQ:AVIR) vs. Regeneron Pharmaceuticals (NASDAQ:REGN) - Defense World

Jan 05, 2026

Jan 04, 2026

What analysts say about Atea Pharmaceuticals Inc stockTrading Volume Trends & Build a Smarter Portfolio Right Now - earlytimes.in

Jan 04, 2026

Jan 03, 2026

What drives Atea Pharmaceuticals Inc stock priceWeekly Market Snapshot & Access Free Risk Analysis Before You Invest - earlytimes.in

Jan 03, 2026

Dec 31, 2025

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 1.4%Here's What Happened - MarketBeat

Dec 31, 2025

Dec 31, 2025

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 1.4% – Here’s What Happened - Defense World

Dec 31, 2025

Dec 23, 2025

Atea Pharmaceuticals: Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026 - Seeking Alpha

Dec 23, 2025

Dec 23, 2025

Atea Pharmaceuticals Completes Patient Enrollment in North American Phase 3 Trial Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus - Sahm

Dec 23, 2025

Dec 23, 2025

Is Atea Pharma Moving BEYOND The Virus And FORWARD To Breakthroughs? - RTTNews

Dec 23, 2025

Dec 22, 2025

Atea Pharmaceuticals Completes Enrollment in North American Phase 3 Trial of Hepatitis C Treatment - marketscreener.com

Dec 22, 2025

Dec 22, 2025

Atea Pharmaceuticals Completes Enrollment in C-BEYOND Phase 3 Trial for HCV Treatment, Anticipates Topline Results in Mid-2026 - Quiver Quantitative

Dec 22, 2025

Dec 22, 2025

Atea Pharmaceuticals Completes Patient Enrollment In North American Phase 3 Trial Evaluating Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C Virus - TradingView — Track All Markets

Dec 22, 2025

Dec 22, 2025

Atea Pharmaceuticals Completes Patient Enrollment in North - GlobeNewswire

Dec 22, 2025

Dec 21, 2025

Published on: 2025-12-21 17:47:39 - Улправда

Dec 21, 2025

Dec 20, 2025

Why analysts upgrade Atea Pharmaceuticals Inc. stockEarnings Overview Report & Stepwise Swing Trade Plans - Улправда

Dec 20, 2025

Dec 20, 2025

Is Atea Pharmaceuticals Inc. stock attractive for ETFsJuly 2025 Macro Moves & Safe Entry Trade Reports - Улправда

Dec 20, 2025

Dec 20, 2025

What is the fair value of Atea Pharmaceuticals Inc. stock nowTreasury Yields & Reliable Trade Execution Plans - Улправда

Dec 20, 2025

Dec 19, 2025

What technical charts say about Atea Pharmaceuticals Inc. stockJuly 2025 Breakouts & Safe Capital Growth Plans - Улправда

Dec 19, 2025

Dec 19, 2025

Aug Catalysts: What is the fair value of Atea Pharmaceuticals Inc. stock nowJuly 2025 Big Picture & Real-Time Stock Entry Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is Atea Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Technicals & Reliable Entry Point Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

How rising interest rates impact Atea Pharmaceuticals Inc. stockEntry Point & Long Hold Capital Preservation Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Atea Pharmaceuticals Inc. stock maintain growth storyTrade Performance Summary & Free Real-Time Volume Trigger Notifications - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Atea Pharmaceuticals Inc. stock deliver strong dividend growthQuarterly Earnings Report & Safe Entry Point Identification - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Chart Watch: Is Atea Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 PreEarnings & Weekly Stock Breakout Alerts - Улправда

Dec 18, 2025

Dec 17, 2025

Nano Dimension And 2 Other Penny Stocks With Promising Potential - simplywall.st

Dec 17, 2025

Dec 17, 2025

Atea Pharmaceuticals Earnings Notes - Trefis

Dec 17, 2025

Dec 16, 2025

Atea Pharmaceuticals (AVIR) Stock Analysis Report | Financials & Insights - Benzinga

Dec 16, 2025

Dec 11, 2025

Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 1.9%Should You Sell? - MarketBeat

Dec 11, 2025

Dec 10, 2025

We're Keeping An Eye On Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Rate - Yahoo Finance

Dec 10, 2025

Dec 04, 2025

How Atea Pharmaceuticals Inc. stock trades during market volatilityTrade Risk Assessment & Community Verified Trade Signals - Newser

Dec 04, 2025

Dec 03, 2025

Is Atea Pharmaceuticals Inc. stock overvalued by current metricsJuly 2025 Macro Moves & Daily Growth Stock Tips - Newser

Dec 03, 2025

Dec 03, 2025

How Atea Pharmaceuticals Inc. stock valuations compare to rivalsTake Profit & Fast Entry High Yield Tips - Newser

Dec 03, 2025

Dec 03, 2025

How Atea Pharmaceuticals Inc. stock performs after earningsJuly 2025 Action & AI Enhanced Trading Signals - Newser

Dec 03, 2025

Nov 25, 2025

ReAlta Life Sciences Appoints Dr. Howard Berman as Executive Chairman - Stock Titan

Nov 25, 2025

Nov 23, 2025

Atea Pharmaceuticals director Franklin Berger acquires $81,498 in stock - MSN

Nov 23, 2025

Nov 21, 2025

Will Atea Pharmaceuticals Inc. stock beat EPS estimatesTrade Risk Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 21, 2025

Nov 20, 2025

Is Atea Pharmaceuticals Inc. stock reversal real or fake2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Will Atea Pharmaceuticals Inc. stock outperform growth indexesJuly 2025 Action & Momentum Based Trading Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

How strong is Atea Pharmaceuticals Inc. stock revenue growth2025 Historical Comparison & Growth Focused Investment Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Atea Pharmaceuticals Inc (AVIR) Q3 2025 Earnings Call Highlights: Strategic Advances in HCV ... By GuruFocus - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference - Yahoo Finance

Nov 19, 2025

Nov 19, 2025

Atea Pharma (NASDAQ: AVIR) hosts Evercore fireside chat Dec. 3 at 10:00 a.m. ET - Stock Titan

Nov 19, 2025

Nov 19, 2025

Is a relief rally coming for Atea Pharmaceuticals Inc. holdersProduct Launch & High Return Trade Opportunity Guides - newser.com

Nov 19, 2025

Nov 18, 2025

How Atea Pharmaceuticals Inc. stock performs in rate cut cyclesQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Nov 18, 2025

Nov 17, 2025

Atea Pharma (AVIR) Earnings Call Transcript - AOL.com

Nov 17, 2025

Nov 17, 2025

William Blair Has Negative Outlook of AVIR FY2025 Earnings - Defense World

Nov 17, 2025

Nov 16, 2025

Atea Pharmaceuticals Inc. stock trend outlook and recovery pathMarket Growth Report & Reliable Price Action Trade Plans - newser.com

Nov 16, 2025